NCT00002524 - Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 1993

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Lymphoma

Interventions

BIOLOGICAL

Bleomycin Sulfate

BIOLOGICAL

Filgrastim

DRUG

Cisplatin

DRUG

Cyclophosphamide

DRUG

Cytarabine

DRUG

Doxorubicin Hydrochloride (DOX)

DRUG

Etoposide

DRUG

Fluorouracil

DRUG

Ifosfamide

DRUG

Leucovorin calcium

DRUG

Methotrexate

DRUG

Methylprednisolone

DRUG

Pentamidine

DRUG

Prednisone

DRUG

Trimethoprim-Sulfamethoxazole

DRUG

Vincristine Sulfate

DRUG

Zidovudine (AZT)

RADIATION

Radiation Therapy

Trial Locations (2)

32806

MD Anderson Cancer Center Orlando, Orlando

77030

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER